These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15107057)
21. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation. Docagne F; Campbell SJ; Bristow AF; Poole S; Vigues S; Guaza C; Perry VH; Anthony DC Eur J Neurosci; 2005 Mar; 21(5):1205-14. PubMed ID: 15813930 [TBL] [Abstract][Full Text] [Related]
22. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism]. Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587 [TBL] [Abstract][Full Text] [Related]
23. The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. Dinarello CA N Engl J Med; 2000 Sep; 343(10):732-4. PubMed ID: 10974140 [No Abstract] [Full Text] [Related]
24. Pathogenesis of bronchopulmonary dysplasia: the role of interleukin 1beta in the regulation of inflammation-mediated pulmonary retinoic acid pathways in transgenic mice. Bry K; Lappalainen U Semin Perinatol; 2006 Jun; 30(3):121-8. PubMed ID: 16813970 [TBL] [Abstract][Full Text] [Related]
25. Interleukin-1 levels in gingival crevicular fluid adjacent to restorations of calcium aluminate cement and resin composite. Konradsson K; van Dijken JW J Clin Periodontol; 2005 May; 32(5):462-6. PubMed ID: 15842260 [TBL] [Abstract][Full Text] [Related]
26. Relationship between the gingival sulcus depth and interleukin-1 isoform concentrations within the adjacent gingival tissue. Lester SR; Bain JL; Serio FG; Johnson RB J Periodontal Res; 2009 Jun; 44(3):323-9. PubMed ID: 18973531 [TBL] [Abstract][Full Text] [Related]
27. [The in situ analysis of cytokine mRNA expression in immunological microenvironment about non-small cell lung cancer]. Chen HW; Li R; Li R; Lai BC; Si LS; Wang YL Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Nov; 21(6):763-6. PubMed ID: 16256041 [TBL] [Abstract][Full Text] [Related]
28. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336 [TBL] [Abstract][Full Text] [Related]
29. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Braundmeier AG; Nowak RA Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716 [TBL] [Abstract][Full Text] [Related]
30. Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells. Hori M; Sawai H; Tsuji Y; Okamura H; Koyama K Connect Tissue Res; 2006; 47(3):124-32. PubMed ID: 16753805 [TBL] [Abstract][Full Text] [Related]
31. Role of matrix metalloproteinases in melanoma cell invasion. Hofmann UB; Houben R; Bröcker EB; Becker JC Biochimie; 2005; 87(3-4):307-14. PubMed ID: 15781317 [TBL] [Abstract][Full Text] [Related]
32. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466 [TBL] [Abstract][Full Text] [Related]
33. Role of Wnt-5A in interleukin-1beta-induced matrix metalloproteinase expression in rabbit temporomandibular joint condylar chondrocytes. Ge X; Ma X; Meng J; Zhang C; Ma K; Zhou C Arthritis Rheum; 2009 Sep; 60(9):2714-22. PubMed ID: 19714632 [TBL] [Abstract][Full Text] [Related]
34. [Structure and function of matrix metalloproteinases]. Olszyński K; Zimowska M Postepy Biochem; 2009; 55(1):76-84. PubMed ID: 19514468 [TBL] [Abstract][Full Text] [Related]
35. Matrix metalloproteinases in kidney disease progression and repair: a case of flipping the coin. Ronco P; Lelongt B; Piedagnel R; Chatziantoniou C Semin Nephrol; 2007 May; 27(3):352-62. PubMed ID: 17533011 [TBL] [Abstract][Full Text] [Related]
36. The effect of IL-1alpha on the expression of matrix metalloproteinases, plasminogen activators, and their inhibitors in osteoblastic ROS 17/2.8 cells. Fujisaki K; Tanabe N; Suzuki N; Mitsui N; Oka H; Ito K; Maeno M Life Sci; 2006 Mar; 78(17):1975-82. PubMed ID: 16313928 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-1 and ischemic brain injury in the newborn: development of a small molecule inhibitor of IL-1 receptor. Quiniou C; Kooli E; Joyal JS; Sapieha P; Sennlaub F; Lahaie I; Shao Z; Hou X; Hardy P; Lubell W; Chemtob S Semin Perinatol; 2008 Oct; 32(5):325-33. PubMed ID: 18929155 [TBL] [Abstract][Full Text] [Related]
38. [Role of interleukin-18, interleukin-1beta and its soluble receptor (sIL-1RII) in early and late Lyme borreliosis]. Pietruczuk A; Swierzbińska R; Pietruczuk M; Hermanowska-Szpakowicz T Pol Merkur Lekarski; 2004 Nov; 17(101):446-50. PubMed ID: 15754629 [TBL] [Abstract][Full Text] [Related]